Induction of the TEAD Co-activator VGLL1 by Estrogen Receptor-Targeted Therapy Drives Resistance in Breast Cancer.
Gemma C, Lai CF, Singh AK, Belfiore A, Portman N, Milioli HZ, Periyasamy M, Raafat S, Nicholls AJ, Davies CM, Patel NR, Simmons GM, Fan H, Nguyen VTM, Magnani L, Rakha E, Martin LA, Lim E, Coombes RC, Pruneri G, Buluwela L, Ali S.
Gemma C, et al. Among authors: martin la.
Cancer Res. 2024 Oct 2:10.1158/0008-5472.CAN-24-0013. doi: 10.1158/0008-5472.CAN-24-0013. Online ahead of print.
Cancer Res. 2024.
PMID: 39356622
Free PMC article.